These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9273895

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pepstatin analogues as novel renin inhibitors.
    Guégan R, Diaz J, Cazaubon C, Beaumont M, Carlet C, Clément J, Demarne H, Mellet M, Richaud JP, Segondy D.
    J Med Chem; 1986 Jul; 29(7):1152-9. PubMed ID: 3543358
    [Abstract] [Full Text] [Related]

  • 27. Comparison of angiotensinogen and tetradecapeptide as substrates for human renin. Substrate dependence of the mode of inhibition of renin by a statine-containing hexapeptide.
    Stammers DK, Dann JG, Harris CJ, Smith DR.
    Arch Biochem Biophys; 1987 Nov 01; 258(2):413-20. PubMed ID: 3314712
    [Abstract] [Full Text] [Related]

  • 28. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
    Rosenberg SH, Plattner JJ, Woods KW, Stein HH, Marcotte PA, Cohen J, Perun TJ.
    J Med Chem; 1987 Jul 01; 30(7):1224-8. PubMed ID: 3298652
    [Abstract] [Full Text] [Related]

  • 29. Statine-containing dipeptide and tripeptide inhibitors of human renin.
    Kokubu T, Hiwada K, Nagae A, Murakami E, Morisawa Y, Yabe Y, Koike H, Iijima Y.
    Hypertension; 1986 Jun 01; 8(6 Pt 2):II1-5. PubMed ID: 3087874
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
    Williams PD, Perlow DS, Payne LS, Holloway MK, Siegl PK, Schorn TW, Lynch RJ, Doyle JJ, Strouse JF, Vlasuk GP.
    J Med Chem; 1991 Mar 01; 34(3):887-900. PubMed ID: 2002469
    [Abstract] [Full Text] [Related]

  • 35. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K, Kamijo T, Harada H, Akahane K, Kubota T, Umeyama H, Ishida T, Kiso Y.
    J Med Chem; 1990 Oct 01; 33(10):2707-14. PubMed ID: 2120440
    [Abstract] [Full Text] [Related]

  • 36. Peptide hairpins with strand segments containing alpha- and beta-amino acid residues: cross-strand aromatic interactions of facing Phe residues.
    Roy RS, Gopi HN, Raghothama S, Gilardi RD, Karle IL, Balaram P.
    Biopolymers; 2005 Oct 01; 80(6):787-99. PubMed ID: 15895435
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Design of potent substrate-analogue inhibitors of canine renin.
    Hui KY, Siragy HM, Haber E.
    Int J Pept Protein Res; 1992 Aug 01; 40(2):152-60. PubMed ID: 1446972
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.